Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/12/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/05/20 | UPLOAD | SEC-generated letter |
|
2 | |
| 06/05/20 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/26/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
15 | |
| 05/20/20 | UPLOAD | SEC-generated letter |
|
4 | |
| 05/20/20 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
37 | |
| 05/18/20 | 8-K | Current report filing |
|
93 | |
| 05/18/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
53 |
| 05/15/20 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 |
